Alkermes Plc at Jefferies London Healthcare Conference Transcript
Let's get started. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to introduce our next company. We have Alkermes and their CEO, Richard Pops, to give us an overview. And also I think, Richard, you recently announced the acquisition of Rodin Therapeutics, I'm sure you're probably going to discuss that as well.
Yes. Good. So then good afternoon, everybody. The presentation is slightly different today than what you might have seen over the past few months. And the title of it is even different, which is this idea that I want to focus your attention on how much is evolving at Alkermes right now. If you haven't been paying attention to Alkermes over the last 4 or 5 months, you probably don't have a very current sense of how dynamic the business is right now and how excited we are about the way the business is evolving.
I will make forward-looking statements, and we always ask you to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |